Franklin Resources Inc. Boosts Position in DaVita Inc. (NYSE:DVA)

Franklin Resources Inc. raised its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 134.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,901 shares of the company's stock after purchasing an additional 31,502 shares during the period. Franklin Resources Inc. owned 0.07% of DaVita worth $8,885,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the stock. FMR LLC boosted its stake in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company's stock worth $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new stake in shares of DaVita in the third quarter valued at approximately $4,094,000. Neo Ivy Capital Management acquired a new stake in shares of DaVita in the third quarter valued at approximately $726,000. Quest Partners LLC purchased a new position in DaVita during the third quarter worth approximately $669,000. Finally, MBB Public Markets I LLC acquired a new position in DaVita during the second quarter worth $582,000. Institutional investors and hedge funds own 90.12% of the company's stock.

DaVita Trading Up 2.9 %

DVA stock traded up $4.31 during mid-day trading on Friday, hitting $151.85. 1,783,892 shares of the company were exchanged, compared to its average volume of 815,299. The business has a fifty day simple moving average of $157.00 and a 200-day simple moving average of $150.93. The firm has a market capitalization of $12.45 billion, a P/E ratio of 16.38, a PEG ratio of 0.86 and a beta of 0.90. DaVita Inc. has a 12-month low of $103.40 and a 12-month high of $169.51. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the firm earned $2.85 earnings per share. The business's revenue was up 4.6% compared to the same quarter last year. On average, equities research analysts predict that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Truist Financial lifted their price target on DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Barclays lifted their target price on shares of DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.